Aura Biosciences, Inc. 4

Jeremy Bender received 30,000 RSUs of Aura Biosciences common stock and a stock option grant for 60,000 shares at $7.03 per share as equity compensation.

On July 7, 2026, Jeremy Bender of Aura Biosciences, Inc. received an equity compensation package consisting of 30,000 shares of common stock via a restricted stock unit (RSU) award and a stock option grant for 60,000 shares at an exercise price of $7.03 per share, with no cash changing hands at grant. The RSUs, each representing one share of common stock, will vest in three substantially equal annual installments beginning on July 15, 2027, contingent on his continued service, while the stock options will vest in three substantially equal annual installments beginning on July 7, 2027 and are exercisable until July 7, 2036. Following these awards, Bender holds 60,000 common shares directly, and the economic value of his equity and options will depend on Aura Biosciences’ future stock price performance as the awards vest and, in the case of options, are exercised.

Filing Facts

CIK

1501796

Ticker

AURA

Form

4

Source Type

fda

Accession

0001193125-26-298542

Alert Tier

5